10157-9077 NDC - IVAREST (ZINC OXIDE, BENZYL ALCOHOL, AND DIPHENHYDRAMINE HYDROCHLORIDE)

Drug Information

Product NDC: 10157-9077

Proprietary Name: Ivarest

Non Proprietary Name: Zinc Oxide, Benzyl Alcohol, and Diphenhydramine Hydrochloride

Active Ingredient(s):
  • 10.5 g/100g BENZYL ALCOHOL;
  • 2 g/100g DIPHENHYDRAMINE HYDROCHLORIDE;
  • 14 g/100g ZINC OXIDE


Administration Route(s): TOPICAL

Dosage Form(s): CREAM

Pharmacy Class(es):
  • Histamine H1 Receptor Antagonists [MoA];
  • Histamine-1 Receptor Antagonist [EPC];
  • Pediculicide [EPC]

Labeler Information

Labeler Name: Blistex Inc
Product Type: HUMAN OTC DRUG
FDA Application Number: part347
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date:12/31/2007

Package Information

No. Package Code Package Description Billing Unit
110157-9077-11 TUBE in 1 CARTON (10157-9077-1) / 56 g in 1 TUBE

NDC Record

Field Name Field Value Definition
PRODUCT NDC10157-9077The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEIvarestThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEZinc Oxide, Benzyl Alcohol, and Diphenhydramine HydrochlorideThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMECREAMThe translation of the dosage form Code submitted by the firm.
ROUTE NAMETOPICALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE12/31/2007This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEOTC MONOGRAPH FINALProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERpart347This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEBlistex IncName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEBENZYL ALCOHOL; DIPHENHYDRAMINE HYDROCHLORIDE; ZINC OXIDEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH10.5; 2; 14 
ACTIVE INGRED UNITg/100g; g/100g; g/100g 
PHARM CLASSESHistamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Pediculicide [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023